ASCO 2022 | Key data in sarcoma presented at ASCO 2022

Brian Van Tine, MD, PhD, Washington University School of Medicine in St.Louis, St Louis, MO, talks on promising new data presented at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting, including data on NY-ESO-1 for myxoid/round cell liposarcoma and the BMI1 inhibitor unesbulin for the treatment of Ewing sarcoma. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.